Trial Profile
A randomized multicentre control trial of stage III non-small cell lung cancer application of concomitant late course accelerated hyperfractionation radiochemotherapy with 3DCRT/PP vs 3DCRT/NP.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Apr 2016
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary) ; Vinorelbine (Primary) ; Cisplatin
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 26 Aug 2009 New trial record